Indian Drugs And Chemicals

What Indian Drugs And Chemicals does

Indian Drugs and Chemicals is a privately held, family-owned pharmaceutical ingredients manufacturer established in 1998 and headquartered in Secunderabad, Hyderabad, India. The company manufactures Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, and fine chemicals, with a specialty position as 'one of the few and largest manufacturers of Biperiden HCL.' Its R&D and quality infrastructure spans a defined set of chemical synthesis capabilities (acylation, aromatisation, alkylation, Beckmann rearrangement, bromination, diazotisation, Friedel-Crafts, halogenation, nitration, oxidation, pressure reduction) and an in-house Gas Chromatography quality control laboratory. Manufacturing capacity is operated through a group structure of three affiliated entities: Hermes Laboratories Pvt. Ltd (Bangalore, 2001), Omshri Labs Pvt Ltd (Indore, veterinary and human APIs), and Lokhith Healthcare Pvt. Ltd (Kota, Rajasthan, a five-acre ISO/GMP contract manufacturing site).

The company's go-to-market is direct enterprise field sales to pharmaceutical companies, with a custom quotation-based pricing model negotiated per customer and product specification. It serves both domestic and international pharmaceutical customers across 14+ countries, including Germany, Egypt, Uruguay, Italy, Iraq, Costa Rica, and Australia. Named enterprise customers include Syngene International, Biocon, Anthem Bioscience, Advinus Therapeutics, Star Pharma (Australia), and Rallis India. Marketing channels are deliberately low-touch — company website, LinkedIn presence, an Instagram handle, and direct email and phone sales outreach — consistent with a long-tenured relationship business.

Revenue is not publicly disclosed and the core direct headcount is small at 12 employees, which points to a lean commercial/coordination core that orchestrates manufacturing across the affiliated facilities rather than running all production in-house. The company has no external institutional investors, no public listing, and no disclosed funding events; ownership remains with the Jatia family, with Ms. Mamta Jatia managing operations and client services and Mr. Shashank More handling techno-commercial functions. There are no patents, regulatory actions, or restructuring events disclosed in the source data.

Name

Indian Drugs And Chemicals

Legal name

Indian Drugs and Chemicals

Website

https://indiandrugs.co.in

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

11–50 employees

Short description

Indian Drugs and Chemicals is a privately held, family-owned API, intermediate, and fine chemical manufacturer based in Hyderabad, India, founded in 1998. It serves domestic and international pharmaceutical companies across 14+ countries via affiliate manufacturing facilities and direct enterprise sales.

Ownership category

akta.pro rank

Product category

Pharmaceutical Ingredients Manufacturing

NAICS

Medicinal and Botanical Manufacturing (325411), Pharmaceutical and Medicine Manufacturing (32541), Chemical Manufacturing (325)

SIC

Medicinal Chemicals & Botanical Products (2833), Chemicals & Allied Products (2800)

akta.pro primary industry

Small-Molecule API Commercial Manufacturing (HLAGAHAB)

akta.pro secondary industries

Generic APIs & Intermediates (Active Ingredients) (HLAIABAG), Small-Molecule API Process Development & Route Scouting (HLAGAHAA), Specialty Pharmaceutical Distributors (HLAIAJAB)

Keywords

• Active pharmaceutical ingredients
• Pharmaceutical intermediates manufacturing
• Fine chemicals production
• API contract manufacturing
• Bulk drug substances

Headquarters

HQ city

Secunderabad, Hyderabad

HQ country

India

HQ region

Asia

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Technology or R&D, Infrastructure, Personnel, Marketing or Sales

Revenue model

1. API and Intermediate Manufacturing: Manufacturing and sale of Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, and fine chemicals to pharmaceutical companies worldwide. Revenue generated through product sales with pricing based on specifications and volumes.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Indian Drugs And Chemicals manufactures and supplies Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, and fine chemicals to pharmaceutical companies in India and 14+ international markets. The company acts as both manufacturer and stockist, with Biperiden HCL as a flagship API offering, leveraging R&D in chemical synthesis and multiple manufacturing facilities including ISO and GMP certified plants operated through sister concerns and contract manufacturing partners.

Product overview

Indian Drugs And Chemicals operates as a pharmaceutical ingredients manufacturer offering a unified portfolio of APIs (Active Pharmaceutical Ingredients), Intermediates, and Fine Chemicals. The company serves as both manufacturer and stockist, with a particular emphasis on Biperiden HCL as a flagship API product. Manufacturing operations are supported by affiliated facilities including Hermes Laboratories Pvt. Ltd. (Bangalore) and Lokhith Healthcare Pvt. Ltd. (Kota, Rajasthan), enabling contract manufacturing and expanded production capacity. The company utilizes latest technologies and R&D capabilities in specialized chemistry processes including acylation, alkylation, oxidation, halogenation, nitration, and bromination to develop products domestically.

Differentiator

Problem solved

Functional benefit

Products and services

• Biperiden HCL Active Pharmaceutical Ingredient (API) — the company claims to be one of the few and largest manufacturers of Biperiden HCL, providing the right grade and quality for pharmaceutical applications.
• Active Pharmaceutical Ingredients (APIs) Bulk actives manufactured for the world pharmaceutical market, including products for human and veterinary applications, produced by Indian Drugs and Chemicals and its sister concerns Hermes Laboratories Pvt. Ltd. (Bangalore) and Omshri Labs Pvt. Ltd. (Indore).
• Pharmaceutical Intermediates Chemical intermediates used in the pharmaceutical manufacturing process, produced at auditable facilities for multinational and domestic pharmaceutical companies.
• Fine Chemicals Specialty fine chemicals manufactured in India, developed through R&D efforts focused on various chemical synthesis processes including acylation, alkylation, oxidation, and halogenation.

Named customers6 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Three partnerships are on record, tiered core.

• Hermes Laboratories Pvt. Ltd (Sister Concern)coreStrategic or Co-development Partner · 1 January 1998Established in 2001 in Bangalore. Sister concern committed to serving high-quality products to leading pharmaceutical companies. Already expanded 80% in terms of area and building. Auditable facility for intermediates.
• Omshri Labs Pvt Ltd (Sister Concern)coreStrategic or Co-development PartnerLocated in Indore. Sister concern catering to a larger market of Human and Veterinary APIs.
• Lokhith Healthcare Pvt. Ltd (Contract Manufacturing)coreStrategic or Co-development PartnerISO, GMP facility in Kota, Rajasthan spread over 5 acres. Contract manufacturing partner for various products catering to customers in India and abroad. Associate concern taken over for contract manufacturing.

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Piramal Pharma Solutions: Large Indian CDMO offering API development, manufacturing, and contract services. Overlaps with IDC on contract manufacturing and small-molecule APIs, but at much larger scale.
• Aurobindo Pharma: Vertically integrated Indian pharma with large API manufacturing operations. Overlaps with IDC in the API/intermediate space as a competitor and potential customer.
• Laurus Labs: Indian API and CDMO serving global pharma with broad small-molecule and synthesis capabilities. Competes in the same specialty/fine chemicals and API space, but at much larger scale.
• Divi's Laboratories: Large Indian API and intermediate manufacturer serving global generics and innovators. Overlaps with IDC on small-molecule APIs and intermediates but at significantly greater scale.
• Granules India: Indian manufacturer of APIs, intermediates, and finished dosages with global customers. Operates in adjacent pharma chemical manufacturing space at larger scale.

Direct peers

• SMS Pharmaceuticals: Indian API and intermediate manufacturer based in Hyderabad with similar scale, export orientation, and customer base of generic and multinational pharma companies. Closest comparable in size and product mix.
• Hikal Ltd: Indian manufacturer of APIs, intermediates, and fine chemicals serving global pharma and agrochemical customers. Closely comparable in chemistry breadth and customer type.
• Neuland Laboratories: Indian API and contract manufacturer offering small-molecule APIs and intermediates to global pharma; similar product portfolio (APIs, intermediates) and international customer focus.
• Sai Life Sciences: Indian API and CDMO offering contract manufacturing and custom synthesis to global pharma. Comparable in offering intermediates and APIs with strong chemistry capabilities.

Emerging players

• CTX Life Sciences: Smaller Indian API and intermediate manufacturer with similar specialty focus and contract manufacturing model. Closest size and product match to IDC in the emerging/small-cap segment.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/indian-drugs-and-chemicals
• Instagraminstagram.com/the_indian_drug?utm_medium=copy_link

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Indian Drugs And Chemicals